Park K H, Bae C W, Chung S J
Department of Pediatrics, Masan Samsung Hospital, Asan Medical Center, Masan, Seoul, Korea.
J Korean Med Sci. 1996 Oct;11(5):429-36. doi: 10.3346/jkms.1996.11.5.429.
The pathophysiology of meconium aspiration syndrome(MAS) is related to mechanical obstruction of the airways and to chemical pneumonitis. Meconium is also suggested to cause functional deterioration of pulmonary surfactant. Recent studies have reported that meconium inhibits the physical surface properties of pulmonary surfactant, and that administration of exogenous surfactant may provide therapeutic benefits in animal models or infants with respiratory distress due to MAS. To assess the effects of meconium on physical surface properties, especially the changes on the air-liquid interface and hypophase of pulmonary surfactant in vitro, we studied the following findings; a) the surface spreading rate(SSR) and the surface adsorption rate(SAR), b) the viscosity, c) the electron microscopic changes, on a series of mixtures with various concentrations of lyophilized human meconium and Surfactant-TA(SurfactenTM). The human meconium has significantly increased the surface tension of SSR and the viscosity of pulmonary surfactant, but had decreased the surface pressure of SAR of surfactant, and changed the electron microscopic findings of surfactant. We have concluded that these findings support the concept that meconium-induced surfactant dysfunction may play a role in the pathophysiology of MAS.
胎粪吸入综合征(MAS)的病理生理学与气道机械性阻塞和化学性肺炎有关。胎粪也被认为会导致肺表面活性物质功能恶化。最近的研究报告称,胎粪会抑制肺表面活性物质的物理表面特性,并且外源性表面活性物质的给药可能对因MAS导致呼吸窘迫的动物模型或婴儿具有治疗益处。为了评估胎粪对物理表面特性的影响,特别是在体外对肺表面活性物质气液界面和亚相的影响,我们研究了以下结果:a)表面铺展速率(SSR)和表面吸附速率(SAR),b)粘度,c)电子显微镜下的变化,针对一系列含有不同浓度冻干人胎粪和表面活性物质TA(SurfactenTM)的混合物。人胎粪显著增加了SSR的表面张力和肺表面活性物质的粘度,但降低了表面活性物质SAR的表面压力,并改变了表面活性物质的电子显微镜观察结果。我们得出结论,这些结果支持以下观点,即胎粪诱导的表面活性物质功能障碍可能在MAS的病理生理学中起作用。